Amplification of the CCND1 gene resulting in cyclin D1 over-expression has been reported to be present in 17% of mutant BRAFV600E melanomas with independent stimulatory effects on cell-cycle progression via CDK4 (Smalley et al, 2008). The gene discussed is CCND1; the disease is melanoma.